|
TNGX Tango Therapeutics Inc 1819133 |
| Balance Sheet |
|
Current Assets
|
266,343,000 |
|
Assets
|
316,492,000 |
|
Current Liabilities
|
38,170,000 |
|
Liabilities
|
116,975,000 |
|
Equity
|
199,517,000 |
|
Shares Out
|
107,144,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-131,501,000 |
|
Investing Cash Flow
|
86,126,000 |
| Market Analysis |
Market Cap
|
921,441,880 |
|
Price
|
1.76 |
|
BVPS
|
1.86 |
|
PB
|
0.92 |
|
EPS
|
-1.11 |
|
PS
|
5.48 |
|
FCF
|
-45,375,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-1.19 |
3/18 |
0.12 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TNGX documents filed with the SEC.
TNGX Filings
Clear
